BNET Industries
Market Cap:$14.1M
Last Fiscal Year Sales:$28.6M
- Public
Contact Information
No. 2, Jing You Road
Kunming National Economy &
Technology Developing District 00000
0086-871-7282628
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009
News & Analysis
Filter by
china and china shenghuo pharmaceutical holdings inc. - All News and Analysis
China Shenghuo Reports Large Loss on Higher Revenues
Seeking Alpha
- 2009-05-18
ChinaBio Today submits: China Shenghuo Pharmaceutical Holdings (NYSE Amex Equities: KUN) declared that revenues rose 23% in the first quarter of 2008 to $6.8 million. The numbers raised cash flow to $890,000, but the company reported a net operating loss of $2.9 million, much higher than the $850,000 loss...
China Shenghuo's Revenues Can't Keep Up with Expenses
Seeking Alpha
- 2008-12-10
ChinaBio Today submits: China Shenghuo Pharmaceutical Holdings KUN has resumed trading on the NYSE Alternext US exchange. In early action, the price of its shares was cut in half, dropping 98 cents (52%) to $.91. The company’s stock was suspended from trading in late August because China...
China Biotech Week in Review: Earnings Turn Negative
Seeking Alpha
- 2008-08-24
ChinaBio Today submits: Earnings reports for China biomedical companies continued to be released during the past five days, though their pace dropped markedly from the week earlier. And the tone changed as well, turning more negative. In all, three companies reported, and Lotus Pharma [LTUS.OB] produced the most...
China Shenghuo Pharma to Restate Financial Results, Faces Potential De-listing from AMEX
Seeking Alpha
- 2008-08-21
ChinaBio Today submits: China Shenghuo Pharmaceutical Holdings, Inc. KUN will restate its financial reports from the past twelve months, saying that the company has discovered errors in sales commission advances and trade receivables. The Audit Committee and an independent counsel will review Shenghuo’s internal controls and the personnel who...
- 1
| Volume | 13,200 |
| Shares Outstanding | 19.6M |
| Market Cap | 14.1M |
| Year High | 1.25 |
| Year Low | 0.16 |
| Earnings Per Share | -0.37 |
| P/E Ratio | N/A |
| Dividend | 0.00 |
| Yield | 0.00 |
Industry Transcripts by Seeking Alpha
-
Martek Biosciences Corporation F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 16, 2009about MATK
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
Glass Door
Pharma Industry Companies
| Company | Employer Rating |
| Johnson & Johnson |  |
| Merck | |
| Pfizer | |
| Novartis |  |
| Abbott Labs | |
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
Presented by American Express